Ku-Shark Tank India isizini yesi-2, imibono eminingi yebhizinisi ehlukile iyakwazi ukukhulisa ukutshalwa kwezimali, iphile ngokuvumelana nokulindelwe oShaka. I-CureSee Vision Therapy ku-Shark Tank India ingomunye umbono woguquko we-AI -Osuselwe ohlabe amajaji umxhwele futhi wawenza alwela isivumelwano.
Uhlelo lwethelevishini lwangempela i-Shark Tank India inikeza ithuba kosomabhizinisi abavela ezweni lonke ukuthi baveze imibono yabo yebhizinisi kuphaneli yabatshalizimali abangaba abatshalizimali. Ithimba loshaka libe selitshala eyalo imali kulo mbono ukuze libe nengxenye yobunikazi enkampanini.
Ngemva kwesizini 1, umbukiso uhehe igagasi losomabhizinisi abafuna uxhaso, futhi esiqeshini sokugcina, inkampani ebizwa ngokuthi iCureSee yaveza umbono wabo. Isikhulu seLenskart uPiyush Bansal wenze isivumelwano nayo ngemuva kokuthi ihlabe umxhwele amajaji. Nakhu konke okwenzeka ohlelweni.
Okuqukethwe
I-CureSee Vision Therapy ku-Shark Tank India
Ku-Shark Tank India Isiqephu sesi-2 Isiqephu 34, abameleli be-CureSee Vision Therapy benze ukuba khona kwabo kuzwakale ngokwethula i-World's 1st Artificial Intelligence Intelligence (AI) based Vision Therapy Software ye-Amblyopia noma iso Lazy. Kwenze uNamita Thapar uMqondisi we-Emcure Pharmaceuticals kanye nomsunguli we-Piyush Bansal kanye ne-CEO yempi edumile ye-Lenskart yokuthola isivumelwano.
Bobabili babefuna ukutshala imali ngemuva kokuzwa i-pitch futhi baqala ukuchaza imibono yabo yenkampani ye-AI-based vision therapy. Ngokwenza kanjalo, uBansal udelela umbono ngamunye kaThapar wezimbiza, okuholela ekutheni bobabili babuzane.
UBansal uthi akakholelwa kumodeli uThapar awukhethele inkampani. Uthi akazange aqonde kubo njengoba efunda ngomsamo, ngakho akazange asondele kubo. UThapar ubuza ukuthi kungani engakaze asondele kubo lapho ezwa ngesikhulumi.
Izinto zaba mnandi kakhulu lapho bobabili bebambene ngezihluthu. INamita iqale yanikeza ama-Rs 40 lakh ngokulingana ngamaphesenti angama-7.5, kwathi uPiyush wanikeza ama-Rs 40 lakh ngokulingana kwamaphesenti ayishumi. Ngokulandela amagama aqinile nempi yokubhida, abamele i-CureSee bakhethe ukunikezwa okubuyekeziwe kuka-Piyush kwama-lakhs angama-10 ngokulingana okungu-50%.
I-CureSee Vision Therapy ku-Shark Tank India - Amaphuzu Avelele Amakhulu
| Igama Lokuqalisa | I-CureSee Vision Therapy |
| Ukuqala Mission | Nikeza ukwelashwa komuntu siqu nokuguquguqukayo ezigulini ezine-amblyopia zisebenzisa i-AI |
| Igama Lomsunguli we-CureSee | Puneet, Jatin Kaushik, Amit Sahn |
| Ukufakwa kwe-CureSee | 2019 |
| CureSee Initial Buza | ₹40 lakhs ngokulingana okungu-5%. |
| Ukulinganisa Kwenkampani | Ama-R5 wezigidi |
| I-CureSee Idili Ku-Shark Tank | ₹50 lakhs ngokulingana okungu-10%. |
| Abatshalizimali | I-Piyush Bansal |
Iyini i-CureSee Vision Therapy
Abasunguli bathi i-CureSee iyisoftware yokuqala esekelwe kumbono we-Artificial Intelligence (AI) emhlabeni eyelapha i-Amblyopia. Izinhlobonhlobo zokuzivocavoca zinikezwa ukuthuthukisa ukubona kanye nenani lezinhlelo zokusiza ukulwa nezinkinga zamehlo njenge-amblyopia.
Wonke umuntu angazuza kulolu hlelo lokuvivinya amehlo olubanika amandla futhi luthuthukise umbono wabo. Noma ubani angayisebenzisa, kungakhathaliseki ubudala babo noma ikhono lokubona. Kulula ukuyisebenzisa futhi ifinyeleleka kunoma iyiphi indawo. Njengoba lolu hlelo luvimbela futhi lunciphisa ubungozi bezinkinga zokubona, luyisinqumo esihle kubantu abafuna ukugcina impilo enhle yamehlo.
I-Amblyopia Exercises wuhlelo olukhethekile olwakhelwe iziguli ezine-amblyopia, evame ukubizwa ngokuthi “iso elivilaphayo”. Ngokusetshenziswa kobuchwepheshe be-intelligence yokwenziwa obusezingeni eliphezulu, uhlelo luhlinzeka ngokuzivocavoca komuntu ngamunye, okuguquguqukayo okusekelwe ekuqhubekeleni phambili komsebenzisi ngamunye. Iziguli ze-Amblyopia zingakwazi ukuphinde zibone futhi zithuthukise ukubona kwazo ngalolu hlelo, okutholakale ukuthi luyindlela yokwelapha ephumelela kakhulu.
Le nkampani inabasunguli abathathu kanye nezikhulu ezintathu eziyinhloko: uPuneet, uJatin Kaushik no-Amit Sahni. Ngokusekelwe olwazini olunikezwe abasunguli, selaphe cishe iziguli ezingama-2500 kusukela ngo-2019. Njengamanje, inkampani inodokotela abangaphezu kuka-200 futhi isebenza ezindaweni ezingaphezu kuka-40.
Ungahle ufune nokuhlola CloudWorx Ku-Shark Tank India
Isiphetho
I-CureSee Vision Therapy On Shark Tank India ikwazile ukuhlaba umxhwele wonke amajaji futhi yasayina isivumelwano noshaka ohlobene nebhizinisi labo futhi ongabasiza kakhulu. Ngokusho koshaka abakulolu hlelo, luyisiqalo esizosiza abantu abaningi abanenkinga yamehlo.